Entries by Citron Research

, ,

Could TransDigm be the Valeant of the Aerospace Industry?

Wall Street:  Be Careful!  President Trump has become to Aerospace what Hillary was to Pharmaceuticals   President Trump has promised to end the long-standing, infuriating tradition of “sticking the US Government with tab”.  He has already made lowering prices for military aircraft a pillar of his transition into office. President Trump has already met with […]

, ,

Citron Exposes More Lies and Deception From Cyberdyne

Cyberdyne stock was up over 10% this week as the company put out a press release that told investors that the company’s regenerative treatment technology had been featured in Nature Magazine as a medical breakthrough.

再生治療技術が、ネイチャーマガジンで、医療の飛躍的進歩 として紹介されたというプレスリリースを公開し、サイバー ダインの株は、今週10%以上上昇している。

, ,

Mallinckrodt CEO FRAUD exposed by the new Medicare Drug Dashboard

Mallinckrodt Stock Target Price – $20   Dear Readers, It has taken too much time but now the truth is out about Mallinckrodt ($MNK). The newly published Medicare dashboard proves that: 1.  As insurance companies have clamped down on reimbursement, tax-inverted Mallinckrodt has dug deeper into the pockets of taxpayer-funded Medicare to peddle its medically […]